Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

BEROTEC TAB 2.5MG 2.5 MG — DIN 00454796

FENOTEROL HYDROBROMIDE : 2.5 MG · BOEHRINGER INGELHEIM (CANADA) LTD LTEE · TABLET · wholesale supply in Canada

Health Canada status: CANCELLED POST MARKET

What is BEROTEC TAB 2.5MG?

BEROTEC TAB 2.5MG 2.5 MG contains FENOTEROL HYDROBROMIDE : 2.5 MG. It is listed in the Health Canada Drug Product Database under DIN 00454796, held by BOEHRINGER INGELHEIM (CANADA) LTD LTEE, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled post market, status dated 31-Jul-2000. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

How much does Fenoterol cost around the world?

Fenoterol is listed on 4 of the national price registers Nexara ingests. Each country publishes on a different basis, so those figures are not comparable with one another — or with a Canadian wholesale price.

What a market publishes matters more than the number it publishes. Austria publishes a KVP (Kassenverkaufspreis); Czechia publishes a max producer price (ex-factory); Luxembourg publishes a reimbursement. Comparing an ex-factory ceiling against a pharmacy public price tells you nothing about either, and comparing either against a Canadian landed cost tells you less.

MarketPrice basis published thereBrandsPacks listedRange
AustriaKVP (Kassenverkaufspreis)33EUR███.██
Czechiamax producer price (ex-factory)33CZK███.██
South Africasingle exit price33ZAR███.██
Luxembourgreimbursement22EUR███.██

11 pack listings across 11 brand entries and 4 price bases, refreshed 05 Sep 2026. Ranges span every Fenoterol pack in that market, so a high figure is usually a larger pack rather than the same product.

Figures are held for the Nexara team. Cross-market prices are published on incompatible bases and are not an offer, a landed cost, or a guide to what any buyer can obtain. Nexara publishes which markets list the product and on what basis; the numbers stay internal.

Team sign-in

This table is a regulatory record of where the molecule is listed. The DIN on this page is no longer authorized for sale in Canada, so Nexara does not quote it — see the alternatives above.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label2.5 MG
Dosage formTABLET
RouteORAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceFenoterol
ATC codeR03CC04
AHFS class12:12.00
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)00454796
DIN (unpadded, as printed on some documents)454796
Brand nameBEROTEC TAB 2.5MG
Generic / active ingredientFENOTEROL HYDROBROMIDE : 2.5 MG
Market authorization holderBOEHRINGER INGELHEIM (CANADA) LTD LTEE
Health Canada schedulePrescription
ATC codeR03CC04
ATC anatomical main groupR — Respiratory system
ATC therapeutic subgroupR03CC
Current statusCANCELLED POST MARKET
Status date31-Jul-2000
Original market date1979-12-31 00:00:00
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

2 · Same class — other molecules in ATC R03CC

MoleculeCanadian brandsDINsMarketedSourceable
SalbutamolAPO-SALVENT TABLETS - 2MG · APO-SALVENT TABLETS - 4MG · NOVO-SALMOL INHALER 100MCG/AEM · NOVO-SALMOL TAB 2MG · +16 more201Yes
TerbutalineBRICANYL TAB 2.5 MG · BRICANYL TAB 5 MG20Not in Canada
FenoterolBEROTEC TAB 2.5MG10Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC R03C

ATC subgroupMoleculesDINsMarketed
R03CAEphedrine140
R03CBOrciprenaline70

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

What else is BEROTEC TAB 2.5MG called?

The same molecule, Fenoterol, is registered under other names elsewhere. Buyers and prescribers searching from outside Canada — or working from a foreign prescription or tender document — often know it by one of these:

NameScriptRegistered in
Atrovent Beta U.D.VLatinSouth Africa
BERODUALLatinCzechia
Berodual DosieraerosolLatinAustria
BERODUAL NLatinCzechia
Berodualin Inh.lsg.LatinAustria
VETUNOLatinCzechia

Names are taken from national medicine registers and published price lists. A product registered abroad is not authorized for sale in Canada unless it holds its own DIN; import is possible only through the routes Health Canada permits.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled post market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 00454796. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.